Kate E Broderick Selected Research

reluscovtogene ralaplasmid

1/2022	Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates.
10/2021	Intradermal-delivered DNA vaccine induces durable immunity mediating a reduction in viral load in a rhesus macaque SARS-CoV-2 challenge model.
1/2021	One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model.
1/2020	Immunogenicity of a DNA vaccine candidate for COVID-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kate E Broderick Research Topics

Disease

18	Infections 01/2022 - 02/2013
16	Human Influenza (Influenza) 04/2020 - 10/2010
7	Communicable Diseases (Infectious Diseases) 01/2020 - 09/2012
6	COVID-19 01/2022 - 01/2020
6	Neoplasms (Cancer) 11/2020 - 10/2012
4	Inflammation (Inflammations) 09/2012 - 05/2005
3	Weight Loss (Weight Reduction) 04/2020 - 01/2016
3	Viremia 01/2019 - 02/2013
3	Pneumonia (Pneumonitis) 01/2017 - 10/2013
2	Lyme Disease (Disease, Lyme) 01/2020 - 01/2019
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2020 - 08/2015
2	Tuberculosis (Tuberculoses) 01/2019 - 06/2012
2	Ebola Hemorrhagic Fever 11/2018 - 12/2017
2	Lassa Fever (Fever, Lassa) 12/2017 - 12/2017
2	Uterine Cervical Dysplasia 11/2015 - 10/2012
2	Malaria 01/2014 - 06/2012
1	Fever (Fevers) 01/2021
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 01/2021
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021
1	Melanoma (Melanoma, Malignant) 11/2020
1	Rubella (German Measles) 01/2020
1	Blister (Bulla) 10/2019
1	Diphtheria 01/2019
1	Viral Hemorrhagic Fevers (Viral Hemorrhagic Fever) 01/2019
1	Vaccinia 01/2018
1	Coinfection 12/2017
1	Virus Diseases (Viral Diseases) 11/2017
1	Bacterial Infections (Bacterial Infection) 01/2017
1	Zika Virus Infection 01/2016
1	Toxoplasmosis 01/2016
1	Erythema 11/2015
1	Injection Site Reaction 11/2015
1	Dengue (Dengue Fever) 07/2015
1	Hepatitis C 01/2014
1	Experimental Melanoma 03/2013
1	Pain (Aches) 10/2012
1	HIV Infections (HIV Infection) 06/2012
1	Chronic Disease (Chronic Diseases) 12/2007
1	Heart Failure 06/2007
1	Hypertensive Crisis 06/2007
1	Osteosarcoma (Osteogenic Sarcoma) 05/2007
1	Sepsis (Septicemia) 09/2006
1	Cardiomegaly (Heart Hypertrophy) 05/2005
1	Hypersensitivity (Allergy) 07/2004
1	Ganglion Cysts (Ganglion) 05/2002

Drug/Important Bio-Agent (IBA)

33	VaccinesIBA 01/2022 - 10/2010
20	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 09/2012
19	DNA VaccinesIBA 01/2022 - 10/2010
10	AntigensIBA 01/2020 - 01/2011
8	A-Form DNA (A-DNA)IBA 11/2020 - 01/2011
5	Monoclonal AntibodiesIBA 01/2020 - 01/2017
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2013
5	AntibodiesIBA 01/2020 - 01/2017
5	NucleoproteinsIBA 01/2019 - 09/2011
4	reluscovtogene ralaplasmidIBA 01/2022 - 01/2020
4	EpitopesIBA 11/2020 - 01/2016
4	Immunoglobulin G (IgG)IBA 11/2018 - 02/2013
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2007 - 07/2004
3	Hemagglutinins (Hemagglutinin)IBA 04/2020 - 01/2018
2	NanovaccinesIBA 11/2020 - 04/2020
2	Glycoproteins (Glycoprotein)IBA 01/2019 - 11/2018
2	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2018 - 01/2018
2	Formaldehyde (Formol)FDA Link 11/2017 - 01/2017
2	Respiratory Syncytial Virus VaccinesIBA 11/2017 - 01/2017
2	InterferonsIBA 01/2016 - 10/2012
2	Peptides (Polypeptides)IBA 01/2016 - 05/2002
1	Polysaccharides (Glycans)IBA 01/2022
1	Combined VaccinesIBA 01/2021
1	Protein Subunit VaccinesIBA 11/2020
1	Recombinant ProteinsIBA 11/2020
1	SurvivinIBA 01/2020
1	Cancer VaccinesIBA 01/2020
1	Rubella VaccineIBA 01/2020
1	Broadly Neutralizing AntibodiesIBA 01/2020
1	Codon (Codons)IBA 01/2019
1	AIDS VaccinesIBA 01/2018
1	env Gene ProductsIBA 01/2018
1	ProteomeIBA 01/2018
1	VGX-3100IBA 11/2015
1	Nucleic AcidsIBA 07/2015
1	Neutralizing AntibodiesIBA 07/2015
1	Synthetic Vaccines (Recombinant Vaccines)IBA 03/2013
1	Interleukin-12 (IL 12)IBA 03/2013
1	EnzymesIBA 10/2012
1	avian influenza A virus hemagglutininIBA 06/2012
1	Small Interfering RNA (siRNA)IBA 02/2012
1	SolutionsIBA 10/2010
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 06/2007
1	8-((4-chlorophenyl)thio)cyclic-3',5'-GMPIBA 05/2007
1	C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA 05/2007
1	Interleukin-6 (Interleukin 6)IBA 05/2007
1	cobinamideIBA 09/2006
1	Natriuretic PeptidesIBA 05/2005
1	Cyclic GMPIBA 05/2005
1	NeuropeptidesIBA 07/2004

Therapy/Procedure

5	Therapeutics 01/2020 - 01/2016
4	Immunotherapy 01/2020 - 03/2013
1	Art Therapy 01/2020
1	Jet Injections 10/2019